GlassScriptPhysician profile
Parul Jandir
NPI 1710514096
$822.98
in general payments reported to CMS, 2019-2025
8 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $16.90 · 2024: $458 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $544 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.00 |
| Education | $278.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $214.98 | 2024 | Jakafi |
| Gilead Sciences, INC. | $205.01 | 2025 | Trodelvy |
| Pharmacosmos Therapeutics INC. | $124.97 | 2025 | Cosela |
| Intera Oncology, INC | $115.02 | 2024 | Intera |
| Genmab U.S., INC. | $110.18 | 2024 | Epkinly |
| Abbvie INC. | $18.59 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $17.33 | 2024 | |
| Apellis Pharmaceuticals, INC. | $16.90 | 2023 | Empaveli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parul Jandir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.